Dear customer, we are sorry but your browser doesn't support all necessary features for good site view. Please switch to one of the modern browsers (Chrome, Safari, Firefox).
tám SctBio

SCT Cell Manufacturing (SCTbio)

SCTbio (SCT Cell Manufacturing) is a specialized end-to-end CDMO offering full GMP services covering production of Advanced Therapy Medicinal Products (ATMPs) including genetically modified and viral vectors.

The SCTbio mission is to serve as the leading engine for the rapidly advancing field of cell and gene therapy by offering a superior, agile approach to GMP manufacturing for its partners.

SCTbio was established on July 1, 2021, as a standalone member of the PPF Group. Our core team carries a 16-year track record in drug development and manufacturing, much of which was forged during our tenure within SOTIO. Today, SCTbio operates a 2,000 m² Prague site integrating state-of-the-art GMP manufacturing, on-site cryostorage, and advanced technical infrastructure.

vědci

All of SOTIO’s cell and gene therapy GMP manufacturing capabilities were outsourced to SCTbio. With headquarters in Prague and offices in Boston, SCTbio manages a global network of 150+ apheresis sites and supports multi-indication clinical programs from early stage through Phase III and later stages.

vědec

The company offers full services covering GMP production of ATMPs including genetically modified cell lines and viral vectors. SCTbio leverages 16 years of experience (encompassing delivering 12,000+ IMPs and collecting 3,000+ leukapheresis products) to provide process development, manufacturing, quality control, QA/QP release, and proprietary logistics services to deliver high-quality collaboration for global CDMO needs.

tám SctBio

Contacts

SCT Cell Manufacturing s.r.o.

Jankovcova 1518/2
170 00 Prague 7
Czech Republic